Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Emergence of cfr

Emergence of cfr Journal of Medical Microbiology (2013), 62, 845–850 DOI 10.1099/jmm.0.051003-0 Emergence of cfr-harbouring coagulase-negative staphylococci among patients receiving linezolid therapy in two hospitals in China 1 2 3 3 2 Xue-Jing Yang, 3 Yan Chen, 3 Qing Yang, Ting-Ting Qu, Li-Lin Liu, 2 2 Hai-Ping Wang and Yun-Song Yu Correspondence Department of Clinical Laboratory, the First Affiliated Hospital, Zhejiang Chinese Medical Yun-Song Yu University, 59 Youdian Road, Hangzhou, Zhejiang 310006, PR China yvys119@163.com Department of Infectious Diseases, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, 3 Qingchun Road, Hangzhou, Zhejiang 310016, PR China State Key Laboratory for Diagnosis and Treatment of Infectious Disease, the First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, Zhejiang 310003, PR China This study reports on the emergence of cfr-harbouring coagulase-negative staphylococci (CoNS) among patients who received linezolid therapy in two hospitals in Hangzhou, China. The mechanisms of resistance and transmission were analysed for these resistant isolates. Eight Staphylococcus capitis isolates, one Staphylococcus epidermidis isolate and one Staphylococcus hominis isolate, obtained from patients who had received linezolid therapy in two hospitals in Hangzhou, China, were confirmed as linezolid resistant, with MICs ranging from 8 to ”1 .256 mg l . http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Medical Microbiology Wolters Kluwer Health

Loading next page...
 
/lp/wolters-kluwer-health/emergence-of-cfr-6t0iy30BS7

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Copyright
© 2013 SGM
ISSN
0022-2615
DOI
10.1099/jmm.0.051003-0
pmid
23449871
Publisher site
See Article on Publisher Site

Abstract

Journal of Medical Microbiology (2013), 62, 845–850 DOI 10.1099/jmm.0.051003-0 Emergence of cfr-harbouring coagulase-negative staphylococci among patients receiving linezolid therapy in two hospitals in China 1 2 3 3 2 Xue-Jing Yang, 3 Yan Chen, 3 Qing Yang, Ting-Ting Qu, Li-Lin Liu, 2 2 Hai-Ping Wang and Yun-Song Yu Correspondence Department of Clinical Laboratory, the First Affiliated Hospital, Zhejiang Chinese Medical Yun-Song Yu University, 59 Youdian Road, Hangzhou, Zhejiang 310006, PR China yvys119@163.com Department of Infectious Diseases, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, 3 Qingchun Road, Hangzhou, Zhejiang 310016, PR China State Key Laboratory for Diagnosis and Treatment of Infectious Disease, the First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, Zhejiang 310003, PR China This study reports on the emergence of cfr-harbouring coagulase-negative staphylococci (CoNS) among patients who received linezolid therapy in two hospitals in Hangzhou, China. The mechanisms of resistance and transmission were analysed for these resistant isolates. Eight Staphylococcus capitis isolates, one Staphylococcus epidermidis isolate and one Staphylococcus hominis isolate, obtained from patients who had received linezolid therapy in two hospitals in Hangzhou, China, were confirmed as linezolid resistant, with MICs ranging from 8 to ”1 .256 mg l .

Journal

Journal of Medical MicrobiologyWolters Kluwer Health

Published: Jun 1, 2013

References